Estela M.F. Muri

958 citations

50 papers · 757 indexed · h-index 15

Organic Chemistry top 5%
- Synthesis and biological activity 6
- Click Chemistry and Applications 6
- Synthesis and Biological Evaluation 5
- Carbohydrate Chemistry and Synthesis 5
Genetics
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 5
Inorganic Chemistry
Toxicology
Oncology
Computational Theory and Mathematics
- Computational Drug Discovery Methods 8
Infectious Diseases
- HIV/AIDS drug development and treatment 6
Molecular Biology
- Biochemical and Molecular Research 5

Co-authors: J. Williamson Marcelo J. Nieto Robert D. Sindelar Sérgio Pinheiro Luiza R.S. Dias Camilo Henrique da Silva Lima Luciano Puzer Octávio Augusto Ceva Antunes
Cited by: Organic Chemistry Genetics Inorganic Chemistry
Journals: Scientific Reports (2 papers)The Journal of Organic Chemistry (1 paper)Tetrahedron Letters (1 paper)
Partner nations: Brazil United States France

In The Last Decade

Estela M.F. Muri

48 papers receiving 740 citations

Peers

Countries citing papers authored by Estela M.F. Muri

Since Specialization

Citations

This map shows the geographic impact of Estela M.F. Muri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estela M.F. Muri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estela M.F. Muri more than expected).

Fields of papers citing papers by Estela M.F. Muri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estela M.F. Muri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estela M.F. Muri. The network helps show where Estela M.F. Muri may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Estela M.F. Muri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Estela M.F. Muri Line = papers co-authored together Estela M.F. Muri links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Statine-based peptidomimetics as SARS-CoV-2 Papain-like protease inhibitors: in Silico and in vitro studies Scientific Reports ·R Pimentel,Priscila Goes Camargo,Pedro Henrique Rodrigues de Alencar Azevedo,Larissa Esteves Carvalho Constant,Samya Ali Abdel Fattah Costa,Diego Allonso,Carlos Rangel Rodrigues,Magaly Girão Albuquerque,Luiza R.S. Dias,Estela M.F. Muri,Camilo Henrique da Silva Lima	2025	0
2	Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro) Scientific Reports ·Pedro H.R. de A. Azevedo,Priscila Goes Camargo,Larissa Esteves Carvalho Constant,Stephany da Silva Costa,Celimar Sinézia,Alice dos Santos Rosa,Daniel Dias Coutinho de Souza,Amanda Resende Tucci,Vivian Neuza dos Santos Ferreira,Thamara Kelcya Fonseca Oliveira,Nathalia Roberto Resende Borba,Carlos Rangel Rodrigues,Magaly Girão Albuquerque,Luiza R.S. Dias,Rafael Garrett,Milene Dias Miranda,Diego Allonso,Camilo Henrique da Silva Lima,Estela M.F. Muri	2024	4
3	Putative Inhibitor of TcCYP51 from a Library of Approved Drugs: A Virtual Screening Study Journal of the Brazilian Chemical Society ·Luiz A.P. Flores-Junior,E. dos Santos,Estela M.F. Muri,Camilo Henrique da Silva Lima,Luiza R.S. Dias	2024	1
4	Biological evaluation and molecular modeling of peptidomimetic compounds as inhibitors for O-GlcNAc transferase (OGT) European Journal of Pharmaceutical Sciences ·Suraby O. Albuquerque,Thalita G. Barros,Luiza R.S. Dias,Camilo Henrique da Silva Lima,Pedro H.R. de A. Azevedo,Luiz A.P. Flores-Junior,E. dos Santos,Hector F.B.R. Loponte,Sérgio Pinheiro,Wagner B. Dias,Estela M.F. Muri,Adriane R. Todeschini	2020	40
5	Trypanocidal activity of new 1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine derivatives: Synthesis, in vitro and in vivo studies Bioorganic & Medicinal Chemistry ·Joana Lucius de Sousa Ribeiro,Júlio C. A. V. Soares,Gisele Bulhões Portapilla,Maiara Voltarelli Providello,Camilo Henrique da Silva Lima,Estela M.F. Muri,Sérgio de Albuquerque,Luiza R.S. Dias	2020	18
6	3-Acyltetramic acids as a novel class of inhibitors for human kallikreins 5 and 7 Bioorganic & Medicinal Chemistry Letters ·Acácio S. de Souza,Barbara D.C. Pacheco,Sérgio Pinheiro,Estela M.F. Muri,Luiza R.S. Dias,Camilo Henrique da Silva Lima,Rafael Garrett,Mariana B. M. de Moraes,Bruno E.G. de Souza,Luciano Puzer	2019	49
7	Synthesis and mechanistic evaluation of novel N ’-benzylidene-carbohydrazide-1 H -pyrazolo[3,4 -b ]pyridine derivatives as non-anionic antiplatelet agents European Journal of Medicinal Chemistry ·André Luiz Lourenço,Raquel Rocha Silva Salvador,Leonardo A. Silva,Max Saito,JULIANA F. R. E MELLO,Lúcio Mendes Cabral,Carlos Rangel Rodrigues,Maria A.F. Vera,Estela M.F. Muri,Alessandra Mendonça Teles de Souza,Charles S. Craik,Luiza R.S. Dias,Helena Carla Castro,P.C Sathler	2017	25
8	Isosorbide-based peptidomimetics as inhibitors of hepatitis C virus serine protease Bioorganic & Medicinal Chemistry Letters ·Aline C. Portela,Thalita G. Barros,Camilo Henrique da Silva Lima,Luiza R.S. Dias,Pedro H.R. de A. Azevedo,Anna Sophia C.L. Dantas,Ronaldo Mohana‐Borges,Gustavo T. Ventura,Sérgio Pinheiro,Estela M.F. Muri	2017	7
9	Discovery of a new isomannide-based peptidomimetic synthetized by Ugi multicomponent reaction as human tissue kallikrein 1 inhibitor Bioorganic & Medicinal Chemistry Letters ·Thalita G. Barros,Jorge A.N. Santos,Bruno E.G. de Souza,Ana Carolina Rennó Sodero,Alessandra Mendonça Teles de Souza,Dayane P. da Silva,Carlos Rangel Rodrigues,Sérgio Pinheiro,Luiza R.S. Dias,Bárbara Abrahim-Vieira,Luciano Puzer,Estela M.F. Muri	2016	7
10	Synthesis, biological evaluation and molecular modeling of pseudo-peptides based statine as inhibitors for human tissue kallikrein 5 European Journal of Medicinal Chemistry ·Lucas Villas Bôas Hoelz,Bruna C. Zorzanelli,Pedro H.R. de A. Azevedo,Silvia G. Passos,Lucas R. de Souza,Marcelo B. Zani,Sérgio Pinheiro,Luciano Puzer,Luiza R.S. Dias,Estela M.F. Muri	2016	11
11	Green Oxidation of Alcohols Revista Virtual de Química ·Bruna C. Zorzanelli,Estela M.F. Muri	2015	2
12	Oxidação de Alcoóis em Química Verde Revista Virtual de Química ·Bruna C. Zorzanelli,Estela M.F. Muri	2015	0
13	Molecular dynamics simulations of the free and inhibitor-bound cruzain systems in aqueous solvent: insights on the inhibition mechanism in acidic pH Journal of Biomolecular Structure and Dynamics ·Lucas Villas Bôas Hoelz,V.F. Leal,Carlos Rangel Rodrigues,Pedro G. Pascutti,Magaly Girão Albuquerque,Estela M.F. Muri,Luiza R.S. Dias	2015	12
14	Isomannide and Derivatives. Chemical and Pharmaceutical Applications Mini-Reviews in Organic Chemistry ·Estela M.F. Muri,Bárbara Abrahim-Vieira,Thalita G. Barros,J. Williamson,Octávio Augusto Ceva Antunes	2010	11
15	A general approach for the synthesis of 5-substituted-4-amino-pyrrolidin-2-ones and 5-substituted-4-amino-3-pyrrolin-2-ones Tetrahedron Letters ·Sérgio Pinheiro,Ronaldo Carneiro da Silva,Acácio S. de Souza,José Walkimar de M. Carneiro,Estela M.F. Muri,Octávio Augusto Ceva Antunes	2009	9
16	Pseudo-peptides derived from isomannide as potential inhibitors of serine proteases Amino Acids ·Estela M.F. Muri,M. Teixeira Gomes,Magaly Girão Albuquerque,Elaine F. F. da Cunha,Ricardo Bicca de Alencastro,J. Williamson,Octávio Augusto Ceva Antunes	2005	7
17	Anti-Helicobacter pylori Agents. An Update Mini-Reviews in Medicinal Chemistry ·Estela M.F. Muri,J. Williamson	2004	14
18	N-t-Boc-amino acid esters of isomannide Potential inhibitors of serine proteases Amino Acids ·Estela M.F. Muri,M. Teixeira Gomes,Josep Costa,Fernando Alencar,Amanda Sales Conniff,Maria de Lourdes Bastos,R. Hernandez-Valdes,Magaly Girão Albuquerque,Elaine F. F. da Cunha,Ricardo Bicca de Alencastro,J. Williamson,Octávio Augusto Ceva Antunes	2004	13
19	Highly Stereocontrolled Synthesis of Natural Barbacenic Acid, Novel Bisnorditerpene from Barbacenia flava The Journal of Organic Chemistry ·Amaury Patin,Alice Kanazawa,Christian Philouze,Andrew E. Greene,Estela M.F. Muri,Eliezer J. Barreiro,P.C.C. Costa	2003	14
20	Hydroxamic Acids as Pharmacological Agents Current Medicinal Chemistry ·Estela M.F. Muri,Marcelo J. Nieto,Robert D. Sindelar,J. Williamson	2002	210

About Estela M.F. Muri

Estela M.F. Muri is a scholar working on Organic Chemistry, Internal Medicine and Computational Theory and Mathematics, having authored 50 papers that have together received 757 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (8 papers), Synthesis and biological activity (6 papers), HIV/AIDS drug development and treatment (6 papers), Click Chemistry and Applications (6 papers), Biochemical and Molecular Research (5 papers), Synthesis and Biological Evaluation (5 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). The work is most often cited by research in Organic Chemistry (368 citations), Genetics (69 citations) and Inorganic Chemistry (70 citations). Estela M.F. Muri has collaborated with scholars based in Brazil, United States and France. Frequent co-authors include J. Williamson, Marcelo J. Nieto, Robert D. Sindelar, Sérgio Pinheiro, Luiza R.S. Dias, Camilo Henrique da Silva Lima, Luciano Puzer, Octávio Augusto Ceva Antunes, O. A. C. Antunes and Mitchell A. Avery. Their work appears in journals such as Scientific Reports, The Journal of Organic Chemistry and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact